Aclaris Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	267	212	58	872	657	203
Market Cap Growth	29.94%	263.06%	-93.30%	32.58%	223.25%	244.36%
Enterprise Value	146	76	-87	668	480	175
Last Close Price	2.42	1.92	0.83	12.36	10.62	5.13
PS Ratio	22.82	14.18	2.38	35.30	131.67	42.84
PB Ratio	2.99	1.71	0.47	5.32	4.51	7.38
P/TBV Ratio	2.99	1.71	0.47	5.51	4.68	9.10
EV/Sales Ratio	12.65	5.06	-	27.04	96.09	36.79
Debt / Equity Ratio	0.02	0.02	0.02	0.01	0.02	0.38
Asset Turnover	0.09	0.09	0.14	0.12	0.04	0.08
Quick Ratio	3.93	3.88	3.86	9.94	8.38	3.69
Current Ratio	3.93	3.99	4.16	10.56	8.94	3.87
Return on Equity (ROE)	-113.23%	-84.46%	-49.88%	-44.01%	-77.33%	-95.12%
Return on Assets (ROA)	-22.98%	-15.72%	-31.67%	-21.04%	-25.38%	-35.87%
Return on Capital Employed (ROCE)	-43.90%	-27.80%	-68.80%	-36.60%	-28.60%	-86.80%
Earnings Yield	-39.44%	-49.76%	-118.96%	-8.28%	-10.21%	-18.37%
FCF Yield	-11.97%	-7.61%	-107.07%	-6.49%	-5.89%	-14.08%
Buyback Yield / Dilution	-62.68%	-10.73%	-7.05%	-14.95%	-33.36%	-2.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.